Wordt geladen...
The evolving role of immuno‐oncology for the treatment of head and neck cancer
Monoclonal antibodies (mAbs) that target immune co‐signaling pathways have the potential to enable immune mediated tumor eradication. While early adoption of these agents for the treatment of advanced squamous cell carcinoma of the head and neck (SCCHN) has produced some astounding clinical successe...
Bewaard in:
| Gepubliceerd in: | Laryngoscope Investig Otolaryngol |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley & Sons, Inc.
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6383301/ https://ncbi.nlm.nih.gov/pubmed/30828620 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/lio2.235 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|